View More Recent Stories
-
Inspire Medical Systems (INSP) PT Lowered to $233 at Piper Sandler Following KOL Checks
-
Inspire Medical Systems (INSP) PT Lowered to $234 at KeyBanc
-
MedTech sector outlook for 2025: Truist Securities
-
Inspire Medical Systems (INSP) PT Lowered to $190 at Stifel, Citing 'Limited Future Revenue Upside'
-
Piper Sandler on Inspire Medical Systems (INSP): 'Recent Stock Move Presents Buying Opportunity'
-
Inspire Medical Systems (INSP) Reports Prelim Q4
-
Piper Sandler on HGNS Devices Following Eli Lilly's Zepbound FDA Indication Approval
-
Medical Technology and Devices: Piper Sandler Shares 'Quick Thoughts on HC Conference in Jan'
-
RBC's Best Picks For 2025 in Medical Supplies & Devices: 'Oasis of Opportunity Awaits as MedTech Momentum Continues'
-
Inspire Medical Systems (INSP) Announces $75M Accelerated Share Buyback
-
Inspire Medical Systems (INSP) PT Raised to $250 at Truist Securities
-
Inspire Medical Systems (INSP) PT Raised to $260 at Piper Sandler
-
Inspire Medical Systems (INSP) PT Raised to $252 at Baird
-
Inspire Medical Systems (INSP) Tops Q3 EPS by 54c, increases guidance
-
Inspire Medical Systems (INSP) PT Raised to $240 at Baird
-
Inspire Medical Systems (INSP) PT Raised to $240 at Truist Securities
-
Lake Street Capital Markets Reiterates Buy Rating on Inspire Medical Systems (INSP)
-
Zurn Elkay Water, Clear Secure, TG Therapeutics, others to join S&P SmallCap 600
-
Inspire Medical Systems (INSP) adds 10% on CEO comments
-
Inspire Medical Systems (INSP) Announces Extension of Private Placement and Closing of First Tranche
-
Inspire Medical Systems (INSP) Announces $150M Share Buyback
-
Inspire Medical Systems (INSP) Announces FDA Approval of the Inspire V System
-
Inspire Medical Systems (INSP) Announces FDA Approval of the Inspire V System
-
Inspire Medical Systems (INSP) PT Lowered to $230 at Jefferies
-
Inspire Medical Systems (INSP) raises guidance
-
Inspire Medical Systems (INSP) Announces Countrywide Reimbursement in France
-
Inspire Medical Systems (INSP) Announces CE Mark Certification under the European Union’s Medical Device Regulation for Inspire Therapy
-
Inspire Medical Systems (INSP) PT Lowered to $217 at Truist Securities
-
Inspire Medical Systems (INSP) PT Lowered to $220 at Baird
-
Inspire Medical Systems (INSP) PT Lowered to $200 at Mizuho
-
Piper Sandler Reiterates Overweight Rating on Inspire Medical Systems (INSP)
-
ResMed, Inspire Medical slump after Lilly's positive Zepbound data; Citi downgrades
-
ResMed (RMD), Inspire Medical (INSP) sink following Lilly's sleep apnea results
-
Inspire Medical Systems (INSP) PT Lowered to $170 at Stifel Following Lilly's SURMOUNTOSA data
-
Inspire Medical Systems (INSP) PT Lowered to $175 at CFRA
-
6 MedTech stocks to own - KeyBanc

